細胞増殖市場 : 2029年までの世界予測

出版：MarketsandMarkets（マーケッツアンドマーケッツ）　出版年月：2024年3月

Cell Expansion Market – Global Forecasts to 2029

細胞増殖市場 : 製品 [消耗品 (培地、血清、試薬、容器)、機器 (細胞増殖システム、バイオリアクター、インキュベーター)]、細胞タイプ [ヒト、動物 (CHO、mESC)]、用途 (ワクチン、mAb、CGT)、エンドユーザー – 2029年までの世界予測
Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User – Global Forecast to 2029

お問合せ・ご注文　　価格・納期について

Report Overview

The cell expansion market is projected to reach USD 26.7 billion by 2029 from an estimated USD 14.3 billion in 2024, at a CAGR of 13.3% during the forecast period of 2024 to 2029.

細胞増殖市場は、2024年から2029年の予測期間中にCAGR 13.3%で、2024年の推定143億ドルから2029年までに267億ドルに達すると予測されています。

The growth of this market can be attributed to increasing prevalence of chronic diseases. The rising rate of chronic diseases such as cancer is propelling the need of cell based therapies such as cell & gene therapy, tissue engineering, and regenerative medicine. The rising deamd for innovative cell based therapies and novel therapeutics is propelling the need of cell expansion. This trend is expected to drive the growth of the cell expansion market in the coming years.

“The biopharmaceutical production segment accounted for the largest share of by application segment in 2023.”
In 2023, the biopharmaceutical production segment accounted for the largest share of by application segment in the global cell expansion market. Biopharmaceutical production include monoclonal antibody production, vaccine production, and other therapeutic protein production. The growing investments and fundings for the development of novel drug products and rising demand for biological therapies such as monoclonal antibosies, vaccines, and therapeutic proteins are promoting the growth of biopharmaceutical production in cell expansion market.

“The US has continued to dominate the cell expansion market during the forecast period of 2024-2029.”
The US dominated the cell expansion market in North America in 2023. The US is the world’s largest biopharmaceutical market and a leader in biopharmaceutical research/investments. Additionally, the US is home to some of the world’s leading academic research institutes, including Harvard University, Stanford University, and the Massachusetts Institute of Technology (MIT). These institutes conduct cutting-edge research in life sciences, including drug discovery and biotechnology, which involve adoption of cell expansion techniques, resulting to propel the market growth. Additionally, increasing fundings in the field of tissue engineering and regenerative medicine are also driving the growth of cell expansion market.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 60% and Demand Side 40%
• By Designation: Managers – 55%, CXO & Directors – 20%, and Executives – 25%
• By Region: North America – 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

• Thermo Fisher Scientific Inc. (US)
• Danaher Corporation (US)
• Merck KGaA (Germany)
• Sartorius AG (Germany)
• Corning Incorporated (US)
• Lonza (Switzerland)
• Terumo Corporation (Japan)
• Eppendorf SE (Germany)
• FUJIFILM Corporation (Japan)
• Bio-Techne (US)
• Repligen Corporation (US)
• Getinge AB (Sweden)
• Miltenyi Biotec (Germany)
• PerkinElmer Inc. (US)
• STEMCELL Technologies (Canada)
• PromoCell GmBHGmbH (Germany)
• HiMedia Laboratories (India)
• BD (US)
• Takara Bio Inc. (Japan)
• Shanghai Duoning Biotechnology Co., Ltd. (Japan)
• REPROCELL Inc. (Japan)
• PBS Biotech, Inc. (US)
• ACROBiosystems (US)
• Solida Biotech GmBH (Germany)
• Beijing CytoNiche Biotechnology Co., Ltd. (China)
• Neuromics (US)
• Bionet (Spain)
• Cellexus (UK)

Research Coverage:
This research report categorizes the cell expansion market by product (consumables and equipment), by cell type (human cells, animal cells, and other cell types), by application (biopharmaceutical production, tissue engineering & regenerative medicine, drug screening & development, and other applications), by end user (pharmaceutical & biotechnology companies, research & academic institutes, hospitals & diagnostic laboratories, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the cell expansion market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. Also, it include new product launches, collaborations and acquisitions, and recent developments associated with the cell expansion market.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell expansion market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:
• Analysis of key drivers (increasing prevalence of chronic diseases, rising investments and fundings in cell based research, and growing strategic alliances for the development of biotechnology industry), restraints (high cost of cell based therapies and ethical concern regarding cell biology), opportunities (growing opportunities in emerging economies, advances in 3D cell expansion technology), and Challenges (concern regarding supply chain and logistics) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the cell expansion market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell expansion market
• Competitive Assessment: Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Sartorius AG (Germany), Corning Incorporated (US), Lonza (Switzerland), Terumo Corporation (Japan), Eppendorf SE (Germany), FUJIFILM Corporation (Japan), Bio-Techne (US), Repligen Corporation (US), Getinge AB (Sweden), Miltenyi Biotec (Germany), PerkinElmer Inc. (US), STEMCELL Technologies (Canada), PromoCell GmBH (Germany), HiMedia Laboratories (India), BD (US), Takara Bio Inc. (Japan), Shanghai Duoning Biotechnology Co., Ltd. (Japan), REPROCELL Inc. (Japan), PBS Biotech, Inc. (US), ACROBiosystems (US), Solida Biotech GmBH (Germany), Beijing CytoNiche Biotechnology Co., Ltd. (China), Neuromics (US), Bionet (Spain), and Cellexus (UK), among others in the market

Table of Contents

1            INTRODUCTION            84

1.1         STUDY OBJECTIVES      84

1.2         MARKET DEFINITION   84

1.2.1      INCLUSIONS AND EXCLUSIONS OF STUDY         85

1.3         STUDY SCOPE  85

1.3.1      MARKET SEGMENTATION         86

1.3.2      REGIONS COVERED      87

1.4         YEARS CONSIDERED     87

1.5         CURRENCY        88

1.6         STAKEHOLDERS            88

1.7         LIMITATIONS   88

1.8         SUMMARY OF CHANGES            89

1.9         RECESSION IMPACT      90

2            RESEARCH METHODOLOGY     91

2.1         RESEARCH DATA           91

FIGURE 1           RESEARCH DESIGN       91

2.1.1      SECONDARY DATA       92

2.1.2      PRIMARY DATA 93

FIGURE 2           BREAKDOWN OF PRIMARIES: CELL EXPANSION MARKET              93

2.2         MARKET ESTIMATION METHODOLOGY            94

FIGURE 3           CELL EXPANSION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023             94

2.3         BOTTOM-UP APPROACH           94

FIGURE 4           MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023             95

FIGURE 5           REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC. (2023)            95

2.4         INSIGHTS FROM PRIMARY EXPERTS      96

FIGURE 6           MARKET SIZE VALIDATION FROM PRIMARY SOURCES  96

2.5         TOP-DOWN APPROACH             97

FIGURE 7           MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH       97

2.6         GROWTH FORECAST    98

FIGURE 8           CELL EXPANSION MARKET: CAGR PROJECTIONS           98

2.7         MARKET BREAKDOWN AND DATA TRIANGULATION    99

FIGURE 9           DATA TRIANGULATION METHODOLOGY         99

2.8         RESEARCH ASSUMPTIONS         100

2.9         MARKET FORECAST      100

TABLE 1             FACTOR ANALYSIS        100

2.10       RISK ANALYSIS 101

2.11       RECESSION IMPACT ANALYSIS 101

3            EXECUTIVE SUMMARY 102

FIGURE 10         CELL EXPANSION MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)          102

FIGURE 11         CELL EXPANSION MARKET, BY CELL TYPE, 2024 VS. 2029 (USD MILLION)          103

FIGURE 12         CELL EXPANSION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 103

FIGURE 13         CELL EXPANSION MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)          104

FIGURE 14         GEOGRAPHICAL SNAPSHOT OF CELL EXPANSION MARKET              105

4            PREMIUM INSIGHTS      106

4.1         CELL EXPANSION MARKET OVERVIEW 106

FIGURE 15         GROWING FOCUS ON PERSONALIZED MEDICINE TO DRIVE MARKET            106

4.2         ASIA PACIFIC: CELL EXPANSION MARKET, BY PRODUCT & COUNTRY (2023)   107

FIGURE 16         CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC CELL EXPANSION MARKET IN 2023       107

4.3         CELL EXPANSION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              108

FIGURE 17         CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       108

4.4         CELL EXPANSION MARKET SHARE, BY END USER, 2023  108

FIGURE 18         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023     108

5            MARKET OVERVIEW     109

5.1         INTRODUCTION            109

5.2         MARKET DYNAMICS     109

FIGURE 19         CELL EXPANSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    109

TABLE 2             CELL EXPANSION MARKET: IMPACT ANALYSIS 110

5.2.1      DRIVERS            110

5.2.1.1   Increasing incidence of chronic diseases         110

FIGURE 20         CANCER INCIDENCE, BY REGION, 2022 111

FIGURE 21         US: PERCENTAGE OF DEATHS CAUSED BY HEART DISEASE, 2021      111

5.2.1.2   Rising government investments in cell-based research and therapies        112

5.2.1.3   Growing focus on personalized medicine       112

FIGURE 22         PERCENTAGE OF PERSONALIZED MEDICINES IN FDA’S NEW DRUG APPROVALS, 2015–2022   113

5.2.1.4   Increasing GMP certifications for cell therapy production facilities          113

5.2.1.5   Growing strategic alliances for development of cell-based therapeutics    114

TABLE 3             STRATEGIC ALLIANCES IN CELL-BASED THERAPEUTICS              114

5.2.2      RESTRAINTS     114

5.2.2.1   Ethical concerns regarding research in cell biology       114

5.2.2.2   High cost of cell-based therapies      115

5.2.3      OPPORTUNITIES           115

5.2.3.1   High growth opportunities in emerging markets          115

5.2.3.2   Growing utility of 3D cell expansion technology          116

5.2.3.3   Growing automation in cell therapy manufacturing      116

5.2.4      CHALLENGES   117

5.2.4.1   Concerns regarding supply chain logistics      117

5.2.4.2   Challenges related to scale-up of cell and gene therapies            117

5.3         TECHNOLOGY ANALYSIS           118

5.3.1      KEY TECHNOLOGIES    118

5.3.1.1   Single-use technology        118

TABLE 4             ADVANTAGES OF SINGLE-USE BIOREACTORS AND CONVENTIONAL BIOREACTORS            118

5.3.1.2   Automated cell expansion  119

5.3.2      COMPLEMENTARY TECHNOLOGIES     119

5.3.2.1   High-throughput screening              119

5.3.2.2   Single-cell analysis             119

5.3.3      ADJACENT TECHNOLOGIES      120

5.3.3.1   Microfluidics and organ-on-a-chip   120

5.3.3.2   3D bioprinting     120

5.4         TRADE DATA    121

TABLE 5             IMPORT VALUE FOR CELL CULTURE MEDIA, 2018–2022 (USD THOUSAND)     121

TABLE 6             EXPORT VALUE FOR CELL CULTURE MEDIA, 2018–2022 (USD THOUSAND)     126

TABLE 7             IMPORT VOLUME FOR CELL CULTURE MEDIA, 2018–2022 (TONS) 128

TABLE 8             EXPORT VOLUME FOR CELL CULTURE MEDIA, 2018–2022 (TONS) 132

5.5         SUPPLY CHAIN ANALYSIS          134

FIGURE 23         CELL EXPANSION MARKET: SUPPLY CHAIN ANALYSIS  134

5.6         VALUE CHAIN ANALYSIS            135

FIGURE 24         CELL EXPANSION MARKET: VALUE CHAIN ANALYSIS    135

5.7         PRICING ANALYSIS        136

TABLE 9             AVERAGE SELLING PRICE OF CELL EXPANSION PRODUCTS              136

TABLE 10           AVERAGE SELLING PRICE OF CELL EXPANSION PRODUCTS, BY REGION             137

5.8         ECOSYSTEM ANALYSIS 138

FIGURE 25         CELL EXPANSION MARKET: ECOSYSTEM ANALYSIS       138

5.8.1      RAW MATERIAL VENDORS IN CELL EXPANSION MARKET           138

TABLE 11           CELL CULTURE MARKET: ROLE OF RAW MATERIAL VENDORS              138

5.8.2      PRODUCT VENDORS IN CELL EXPANSION MARKET      139

TABLE 12           CELL EXPANSION MARKET: ROLE OF PRODUCT VENDORS              139

5.8.3      END USERS IN CELL EXPANSION MARKET         139

TABLE 13           CELL EXPANSION MARKET: ROLE OF END USERS           139

5.8.4      REGULATORY BODIES GOVERNING CELL EXPANSION MARKET              140

TABLE 14           CELL EXPANSION MARKET: ROLE OF REGULATORY BODIES              140

5.9         TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS     140

FIGURE 26         TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS              140

5.10       PATENT ANALYSIS        141

5.10.1    METHODOLOGY           141

5.10.2    PATENTS FILED, BY DOCUMENT TYPE, 2014–2024          141

TABLE 15           PATENTS FILED, 2014–2024        141

5.10.3    INNOVATION AND PATENT APPLICATIONS      141

FIGURE 27         TOTAL NUMBER OF PATENTS GRANTED, 2014–2024      142

5.10.4    TOP APPLICANTS          142

FIGURE 28         TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS,  2014–2024       142

TABLE 16           TOP 20 PATENT OWNERS IN CELL EXPANSION MARKET, 2014–2024      143

TABLE 17           PATENTS IN CELL EXPANSION MARKET, 2024   144

5.11       KEY CONFERENCES AND EVENTS          146

TABLE 18           CELL EXPANSION MARKET: KEY CONFERENCES AND EVENTS, 2024–2025          146

5.12       REGULATORY LANDSCAPE       148

5.12.1    REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS          148

TABLE 19           NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS       148

TABLE 20           EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS      148

TABLE 21           ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS      150

TABLE 22           REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS       150

5.12.2    REGULATORY SCENARIO           151

TABLE 23           CELL EXPANSION MARKET: REGULATORY GUIDELINES              151

5.13       PORTER’S FIVE FORCES ANALYSIS         153

TABLE 24           CELL EXPANSION MARKET: PORTER’S FIVE FORCES ANALYSIS              153

5.13.1    THREAT OF NEW ENTRANTS    154

5.13.2    THREAT OF SUBSTITUTES         154

5.13.3    BARGAINING POWER OF SUPPLIERS     154

5.13.4    BARGAINING POWER OF BUYERS           154

5.13.5    INTENSITY OF COMPETITIVE RIVALRY 154

5.14       KEY STAKEHOLDERS AND BUYING CRITERIA    155

5.14.1    KEY STAKEHOLDERS IN BUYING PROCESS         155

FIGURE 29         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL EXPANSION PRODUCTS   155

5.14.2    ROLE OF STAKEHOLDERS IN BUYING PROCESS 155

5.14.3    BUYING CRITERIA FOR CELL EXPANSION MARKET        156

FIGURE 30         KEY BUYING CRITERIA FOR END USERS              156

TABLE 25           BUYING CRITERIA FOR CELL EXPANSION PRODUCTS, BY END USER    156

5.15       INVESTMENT/FUNDING ACTIVITIES    157

6            CELL EXPANSION MARKET, BY PRODUCT          158

6.1         INTRODUCTION            159

TABLE 26           CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          159

6.2         CONSUMABLES 159

TABLE 27           CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)              160

TABLE 28           CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)          160

TABLE 29           NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)          160

TABLE 30           EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161

TABLE 31           ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     161

TABLE 32           LATIN AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          162

TABLE 33           MIDDLE EAST: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     162

TABLE 34           GCC COUNTRIES: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          162

6.2.1      MEDIA 163

TABLE 35           MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)    163

TABLE 36           MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)              164

TABLE 37           NORTH AMERICA: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 164

TABLE 38           EUROPE: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          164

TABLE 39           ASIA PACIFIC: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          165

TABLE 40           LATIN AMERICA: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 165

TABLE 41           MIDDLE EAST: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          165

TABLE 42           GCC COUNTRIES: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 166

6.2.1.1   Serum-free media 166

6.2.1.1.1 Increasing utilization of serum-free components in cell research to promote market growth     166

TABLE 43           SERUM-FREE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)          166

TABLE 44          NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY,  2022–2029 (USD MILLION)          167

TABLE 45           EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     167

TABLE 46           ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          167

TABLE 47           LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          168

TABLE 48           MIDDLE EAST: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          168

TABLE 49           GCC COUNTRIES: SERUM-FREE MEDIA MARKET, BY COUNTRY,  2022–2029 (USD MILLION)          168

6.2.1.2   Classical media & salts       169

6.2.1.2.1 Used in cell expansion to provide supportive environment for growth and proliferation of cultured cells           169

TABLE 50           CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2022–2029 (USD MILLION) 169

TABLE 51           NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 169

TABLE 52           EUROPE: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          170

TABLE 53           ASIA PACIFIC: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 170

TABLE 54           LATIN AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 171

TABLE 55           MIDDLE EAST: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 171

TABLE 56           GCC COUNTRIES: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 171

6.2.1.3   Stem cell culture media      172

6.2.1.3.1 Rising investments and funding in stem cell research to support market growth              172

TABLE 57           STEM CELL CULTURE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION) 172

TABLE 58           NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 172

TABLE 59           EUROPE: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          173

TABLE 60           ASIA PACIFIC: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 173

TABLE 61           LATIN AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 174

TABLE 62           MIDDLE EAST: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 174

TABLE 63           GCC COUNTRIES: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 174

6.2.1.4   Chemically defined media  175

6.2.1.4.1 Increasing number of cell-based research practices to drive market          175

TABLE 64           CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION) 175

TABLE 65           NORTH AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 175

TABLE 66           EUROPE: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 176

TABLE 67           ASIA PACIFIC: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 176

TABLE 68           LATIN AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 177

TABLE 69           MIDDLE EAST: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 177

TABLE 70           GCC COUNTRIES: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 177

6.2.1.5   Specialty media    178

6.2.1.5.1 Growing focus on advancement of regenerative medicine to drive growth 178

TABLE 71           EXAMPLES OF SPECIALTY MEDIA OFFERED BY KEY PLAYERS              178

TABLE 72           SPECIALTY MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)          178

TABLE 73           NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          179

TABLE 74           EUROPE: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 179

TABLE 75           ASIA PACIFIC: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     179

TABLE 76           LATIN AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          180

TABLE 77           MIDDLE EAST: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          180

TABLE 78           GCC COUNTRIES: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          180

6.2.1.6   Other media types             181

TABLE 79           OTHER MEDIA TYPES MARKET, BY REGION, 2022–2029 (USD MILLION)          181

TABLE 80           NORTH AMERICA: OTHER MEDIA TYPES MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 181

TABLE 81           EUROPE: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     182

TABLE 82           ASIA PACIFIC: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          182

TABLE 83          LATIN AMERICA: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          182

TABLE 84           MIDDLE EAST: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          183

TABLE 85           GCC COUNTRIES: OTHER MEDIA TYPES MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 183

6.2.2      REAGENTS        183

6.2.2.1   Rising need for unique signaling molecules for cell proliferation to boost growth              183

TABLE 86           REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)              184

TABLE 87           NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     184

TABLE 88           EUROPE: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          184

TABLE 89           ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 185

TABLE 90           LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 185

TABLE 91           MIDDLE EAST: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 185

TABLE 92           GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     186

6.2.3      SERA     186

6.2.3.1   Growing R&D activities to drive demand for sera         186

TABLE 93           SERA MARKET, BY REGION, 2022–2029 (USD MILLION)  186

TABLE 94           NORTH AMERICA: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 187

TABLE 95           EUROPE: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          187

TABLE 96           ASIA PACIFIC: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          187

TABLE 97           LATIN AMERICA: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          188

TABLE 98           MIDDLE EAST: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          188

TABLE 99           GCC COUNTRIES: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 188

6.2.4      VESSELS            188

TABLE 100         VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)  189

TABLE 101         VESSELS MARKET, BY REGION, 2022–2029 (USD MILLION)              189

TABLE 102         NORTH AMERICA: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 190

TABLE 103         EUROPE: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          190

TABLE 104         ASIA PACIFIC: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          190

TABLE 105         LATIN AMERICA: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 191

TABLE 106         MIDDLE EAST: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 191

TABLE 107         GCC COUNTRIES: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 191

6.2.4.1   Roller/roux bottles            192

6.2.4.1.1 Offer economic mean for large-scale cell expansion     192

TABLE 108         ROLLER/ROUX BOTTLES MARKET, BY REGION, 2022–2029 (USD MILLION)          192

TABLE 109         NORTH AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 193

TABLE 110         EUROPE: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          193

TABLE 111        ASIA PACIFIC ROLLER/ROUX BOTTLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)          193

TABLE 112         LATIN AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 194

TABLE 113         MIDDLE EAST: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 194

TABLE 114         GCC COUNTRIES: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 194

6.2.4.2   Cell factory systems/cell stacks        195

6.2.4.2.1 Provide high-throughput and scalable solutions for large-scale cell expansion              195

TABLE 115         CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2022–2029 (USD MILLION)          195

TABLE 116         NORTH AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      195

TABLE 117         EUROPE: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 196

TABLE 118         ASIA PACIFIC: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      196

TABLE 119         LATIN AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      197

TABLE 120         MIDDLE EAST: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      197

TABLE 121         GCC COUNTRIES: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      197

6.2.4.3   Flasks    198

6.2.4.3.1 Commonly used to offer large surface area for cell expansion     198

TABLE 122         FLASKS MARKET, BY REGION, 2022–2029 (USD MILLION)              198

TABLE 123         NORTH AMERICA: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 198

TABLE 124         EUROPE: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          199

TABLE 125         ASIA PACIFIC: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          199

TABLE 126         LATIN AMERICA: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 199

TABLE 127         MIDDLE EAST: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          200

TABLE 128         GCC COUNTRIES: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 200

6.2.4.4   Multiwell plates   200

6.2.4.4.1 Single platform for multiple processes to obtain high-volume culture       200

TABLE 129         MULTIWELL PLATES MARKET, BY REGION, 2022–2029 (USD MILLION)          201

TABLE 130         NORTH AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 201

TABLE 131         EUROPE: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     201

TABLE 132         ASIA PACIFIC: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          202

TABLE 133         LATIN AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          202

TABLE 134         MIDDLE EAST: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          202

TABLE 135        GCC COUNTRIES: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          203

6.2.4.5   Cell expansion bags            203

6.2.4.5.1 Reduce risk of cross-contamination and ensure consistent culture conditions              203

TABLE 136         CELL EXPANSION BAGS MARKET, BY REGION, 2022–2029 (USD MILLION)          203

TABLE 137         NORTH AMERICA: CELL EXPANSION BAGS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 204

TABLE 138         EUROPE: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          204

TABLE 139         ASIA PACIFIC: CELL EXPANSION BAGS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)          204

TABLE 140         LATIN AMERICA: CELL EXPANSION BAGS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 205

TABLE 141        MIDDLE EAST: CELL EXPANSION BAGS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)          205

TABLE 142         GCC COUNTRIES: CELL EXPANSION BAGS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 205

6.2.4.6   Petri dishes          206

6.2.4.6.1 Ease of use to support market growth             206

TABLE 143         PETRI DISHES MARKET, BY REGION, 2022–2029 (USD MILLION)              206

TABLE 144         NORTH AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     206

TABLE 145         EUROPE: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 207

TABLE 146         ASIA PACIFIC: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 207

TABLE 147         LATIN AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     207

TABLE 148         MIDDLE EAST: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     208

TABLE 149         GCC COUNTRIES: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     208

6.2.5      OTHER CONSUMABLES 208

TABLE 150         OTHER CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)          209

TABLE 151         NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 209

TABLE 152         EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          209

TABLE 153         ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          210

TABLE 154         LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 210

TABLE 155        MIDDLE EAST: OTHER CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)          210

TABLE 156         GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 211

6.3         EQUIPMENT     211

TABLE 157         EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)              211

TABLE 158         EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)              212

TABLE 159         NORTH AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     212

TABLE 160         EUROPE: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          212

TABLE 161         ASIA PACIFIC: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 213

TABLE 162         LATIN AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     213

TABLE 163         MIDDLE EAST: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 213

TABLE 164         GCC COUNTRIES: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     214

6.3.1      BIOREACTORS 214

TABLE 165         BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)              214

TABLE 166         BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)              215

TABLE 167         BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)          215

TABLE 168         NORTH AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          215

TABLE 169         EUROPE: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 216

TABLE 170         ASIA PACIFIC: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     216

TABLE 171         LATIN AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     216

TABLE 172         MIDDLE EAST: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     217

TABLE 173         GCC COUNTRIES: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          217

6.3.1.1   Bioreactors, by Usage        217

6.3.1.1.1 Conventional Bioreactors  217

6.3.1.1.1.1           Widely used for large-scale manufacturing     217

TABLE 174         CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)     218

TABLE 175         NORTH AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            218

TABLE 176         EUROPE: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 218

TABLE 177         ASIA PACIFIC: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 219

TABLE 178         LATIN AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 219

TABLE 179         MIDDLE EAST: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 219

TABLE 180         GCC COUNTRIES: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            220

6.3.1.1.2 Single-use bioreactors       220

6.3.1.1.2.1           Increasing adoption of single-use equipment to boost segment growth              220

TABLE 181         SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 221

TABLE 182         NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 221

TABLE 183         EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          221

TABLE 184         ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 222

TABLE 185         LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 222

TABLE 186         MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 222

TABLE 187         GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 223

6.3.1.2   Bioreactors, by Type          223

6.3.1.2.1 Microcarrier bioreactors    223

6.3.1.2.1.1           Offers high density of cells within small volume of media           223

TABLE 188         MICROCARRIER BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)     224

TABLE 189         NORTH AMERICA: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 224

TABLE 190         EUROPE: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 224

TABLE 191         ASIA PACIFIC: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 225

TABLE 192         LATIN AMERICA: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 225

TABLE 193         MIDDLE EAST: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 225

TABLE 194         GCC COUNTRIES: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 226

6.3.1.2.2 Suspension-based independent bioreactors    226

6.3.1.2.2.1           Offer controlled environment for cell growth—key factor driving market growth   226

TABLE 195         SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY REGION,  2022–2029 (USD MILLION)             227

TABLE 196         NORTH AMERICA: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET,  BY COUNTRY, 2022–2029 (USD MILLION)       227

TABLE 197         EUROPE: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         227

TABLE 198         ASIA PACIFIC: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         228

TABLE 199         LATIN AMERICA: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET,  BY COUNTRY, 2022–2029 (USD MILLION)       228

TABLE 200         MIDDLE EAST: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         228

TABLE 201         GCC COUNTRIES: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET,  BY COUNTRY, 2022–2029 (USD MILLION)       229

6.3.1.2.3 Hollow fiber bioreactors    229

6.3.1.2.3.1           Growing demand for perfusion-based cell expansion to drive growth              229

TABLE 202         HOLLOW FIBER BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)     229

TABLE 203         NORTH AMERICA: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 230

TABLE 204         EUROPE: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 230

TABLE 205         ASIA PACIFIC: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 230

TABLE 206         LATIN AMERICA: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 231

TABLE 207         MIDDLE EAST: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 231

TABLE 208         GCC COUNTRIES: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 231

6.3.1.2.4 Other bioreactors 232

TABLE 209         OTHER BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)          232

TABLE 210         NORTH AMERICA: OTHER BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 232

TABLE 211         EUROPE: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     233

TABLE 212         ASIA PACIFIC: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          233

TABLE 213         LATIN AMERICA: OTHER BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 233

TABLE 214         MIDDLE EAST: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          234

TABLE 215         GCC COUNTRIES: OTHER BIOREACTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 234

6.3.2      AUTOMATED CELL EXPANSION SYSTEMS          234

6.3.2.1   Increasing automation in cell & gene therapy manufacturing to boost demand              234

TABLE 216         AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY REGION,  2022–2029 (USD MILLION)     235

TABLE 217         NORTH AMERICA: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      235

TABLE 218         EUROPE: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)         235

TABLE 219         ASIA PACIFIC: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      236

TABLE 220         LATIN AMERICA: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      236

TABLE 221         MIDDLE EAST: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      236

TABLE 222         GCC COUNTRIES: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      237

6.3.3      OTHER CELL EXPANSION EQUIPMENT 237

TABLE 223         OTHER CELL EXPANSION EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)          237

TABLE 224         NORTH AMERICA: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      238

TABLE 225         EUROPE: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 238

TABLE 226         ASIA PACIFIC: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY,  2022–2029 (USD MILLION)         238

TABLE 227         LATIN AMERICA: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      239

TABLE 228         MIDDLE EAST: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      239

TABLE 229         GCC COUNTRIES: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      239

7            CELL EXPANSION MARKET, BY CELL TYPE        240

7.1         INTRODUCTION            241

TABLE 230         CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)          241

7.2         HUMAN CELLS 241

TABLE 231         CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)     242

TABLE 232         CELL EXPANSION MARKET FOR HUMAN CELLS, BY REGION, 2022–2029 (USD MILLION)          242

TABLE 233         NORTH AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY,  2022–2029 (USD MILLION)          242

TABLE 234         EUROPE: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY,  2022–2029 (USD MILLION) 243

TABLE 235         ASIA PACIFIC: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY,  2022–2029 (USD MILLION)         243

TABLE 236         LATIN AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY,  2022–2029 (USD MILLION)          244

TABLE 237         MIDDLE EAST: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY,  2022–2029 (USD MILLION)         244

TABLE 238         GCC COUNTRIES: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY,  2022–2029 (USD MILLION)          244

7.2.1      STEM CELLS     245

TABLE 239         CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)     245

TABLE 240         CELL EXPANSION MARKET FOR STEM CELLS, BY REGION, 2022–2029 (USD MILLION)          246

TABLE 241         NORTH AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY,  2022–2029 (USD MILLION)          246

TABLE 242         EUROPE: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY,  2022–2029 (USD MILLION) 246

TABLE 243         ASIA PACIFIC: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY,  2022–2029 (USD MILLION) 247

TABLE 244         LATIN AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY,  2022–2029 (USD MILLION)         247

TABLE 245         MIDDLE EAST: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY,  2022–2029 (USD MILLION)         247

TABLE 246        GCC COUNTRIES: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY,  2022–2029 (USD MILLION)         248

7.2.1.1   Adult stem cells   248

7.2.1.1.1 Rising funding for advancement of stem cell-based therapies to drive market              248

TABLE 247         CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY REGION,  2022–2029 (USD MILLION)     249

TABLE 248         NORTH AMERICA: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)  249

TABLE 249         EUROPE: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY,  2022–2029 (USD MILLION)         249

TABLE 250         ASIA PACIFIC: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY,  2022–2029 (USD MILLION)          250

TABLE 251         LATIN AMERICA: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)             250

TABLE 252         MIDDLE EAST: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY,  2022–2029 (USD MILLION)          250

TABLE 253         GCC COUNTRIES: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)  251

7.2.1.2   Embryonic stem cells         251

7.2.1.2.1 Rising prevalence of chronic diseases to support market growth 251

TABLE 254         CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY REGION,  2022–2029 (USD MILLION)     252

TABLE 255         NORTH AMERICA: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY,  2022–2029 (USD MILLION)    252

TABLE 256         EUROPE: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY,  2022–2029 (USD MILLION)          252

TABLE 257         ASIA PACIFIC: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY,  2022–2029 (USD MILLION)             253

TABLE 258         LATIN AMERICA: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY,  2022–2029 (USD MILLION)             253

TABLE 259         MIDDLE EAST: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY,  2022–2029 (USD MILLION)             253

TABLE 260         GCC COUNTRIES: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY,  2022–2029 (USD MILLION)             254

7.2.1.3   Induced pluripotent stem cells         254

7.2.1.3.1 Growing number of collaborations for advancement of iPSC-based therapies to drive market        254

TABLE 261         CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY REGION,  2022–2029 (USD MILLION)   255

TABLE 262         NORTH AMERICA: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)  255

TABLE 263         EUROPE: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS,  BY COUNTRY, 2022–2029 (USD MILLION) 255

TABLE 264         ASIA PACIFIC: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS,  BY COUNTRY, 2022–2029 (USD MILLION) 256

TABLE 265         LATIN AMERICA: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS,  BY COUNTRY, 2022–2029 (USD MILLION) 256

TABLE 266         MIDDLE EAST: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS,  BY COUNTRY, 2022–2029 (USD MILLION) 256

TABLE 267         GCC COUNTRIES: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)  257

7.2.2      DIFFERENTIATED CELLS           257

7.2.2.1   Increasing research activities to drive growth 257

TABLE 268         CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY REGION,  2022–2029 (USD MILLION)     258

TABLE 269         NORTH AMERICA: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY,  2022–2029 (USD MILLION)     258

TABLE 270         EUROPE: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY,  2022–2029 (USD MILLION)          258

TABLE 271         ASIA PACIFIC: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY,  2022–2029 (USD MILLION)     259

TABLE 272         LATIN AMERICA: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY,  2022–2029 (USD MILLION)     259

TABLE 273         MIDDLE EAST: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY,  2022–2029 (USD MILLION)     259

TABLE 274         GCC COUNTRIES: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY,  2022–2029 (USD MILLION)     260

7.3         ANIMAL CELLS 260

TABLE 275         CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)     260

TABLE 276         CELL EXPANSION MARKET FOR ANIMAL CELLS, BY REGION, 2022–2029 (USD MILLION)          261

TABLE 277         NORTH AMERICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY,  2022–2029 (USD MILLION)          261

TABLE 278         EUROPE: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY,  2022–2029 (USD MILLION) 261

TABLE 279         ASIA PACIFIC: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY,  2022–2029 (USD MILLION)         262

TABLE 280         LATIN AMERICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY,  2022–2029 (USD MILLION)          262

TABLE 281         MIDDLE EAST: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY,  2022–2029 (USD MILLION)         262

TABLE 282         GCC COUNTRIES: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY,  2022–2029 (USD MILLION)          263

7.3.1      CHINESE HAMSTER OVARY CELLS         263

7.3.1.1   Growing strategic alliances for development of novel biopharmaceuticals to drive growth   263

TABLE 283         CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS, BY REGION,  2022–2029 (USD MILLION) 264

TABLE 284         NORTH AMERICA: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS,  BY COUNTRY,  2022–2029 (USD MILLION)   264

TABLE 285         EUROPE: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS, BY COUNTRY,  2022–2029 (USD MILLION)           265

TABLE 286         ASIA PACIFIC: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS,  BY COUNTRY, 2022–2029 (USD MILLION)      265

TABLE 287         LATIN AMERICA: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS,  BY COUNTRY, 2022–2029 (USD MILLION)      266

TABLE 288         MIDDLE EAST: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS,  BY COUNTRY, 2022–2029 (USD MILLION)      266

TABLE 289         GCC COUNTRIES: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS,  BY COUNTRY, 2022–2029 (USD MILLION)      266

7.3.2      MOUSE EMBRYONIC STEM CELLS          267

7.3.2.1   Growing research activities to develop innovative therapies to support market growth   267

TABLE 290         CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS, BY REGION,  2022–2029 (USD MILLION) 267

TABLE 291         NORTH AMERICA: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS,  BY COUNTRY, 2022–2029 (USD MILLION)    267

TABLE 292         EUROPE: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS, BY COUNTRY,  2022–2029 (USD MILLION)             268

TABLE 293         ASIA PACIFIC: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS,  BY COUNTRY, 2022–2029 (USD MILLION)    268

TABLE 294         LATIN AMERICA: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS,  BY COUNTRY, 2022–2029 (USD MILLION)    269

TABLE 295         MIDDLE EAST: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS,  BY COUNTRY, 2022–2029 (USD MILLION)    269

TABLE 296         GCC COUNTRIES: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS,  BY COUNTRY, 2022–2029 (USD MILLION)    269

7.3.3      OTHER ANIMAL CELLS 270

TABLE 297         CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY REGION,  2022–2029 (USD MILLION)     270

TABLE 298         NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY,  2022–2029 (USD MILLION)         270

TABLE 299         EUROPE: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY,  2022–2029 (USD MILLION)          271

TABLE 300         ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)             271

TABLE 301         LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY,  2022–2029 (USD MILLION)         272

TABLE 302         MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)           272

TABLE 303         GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY,  2022–2029 (USD MILLION)         272

7.4         OTHER CELL TYPES      273

TABLE 304         CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY REGION,  2022–2029 (USD MILLION)     273

TABLE 305         NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY, 2022–2029 (USD MILLION)   273

TABLE 306         EUROPE: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY,  2022–2029 (USD MILLION)         274

TABLE 307         ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY,  2022–2029 (USD MILLION)          274

TABLE 308         LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY,  2022–2029 (USD MILLION)          275

TABLE 309         MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY,  2022–2029 (USD MILLION)          275

TABLE 310         GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY, 2022–2029 (USD MILLION)   275

8            CELL EXPANSION MARKET, BY APPLICATION   276

8.1         INTRODUCTION            277

TABLE 311         CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          277

8.2         BIOPHARMACEUTICAL PRODUCTION  277

TABLE 312         CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE,  2022–2029 (USD MILLION)     278

TABLE 313         CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION,  2022–2029 (USD MILLION) 278

TABLE 314         NORTH AMERICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          278

TABLE 315         EUROPE: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION,  BY COUNTRY, 2022–2029 (USD MILLION)          279

TABLE 316         ASIA PACIFIC: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION,  BY COUNTRY, 2022–2029 (USD MILLION)          279

TABLE 317         LATIN AMERICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION,  BY COUNTRY, 2022–2029 (USD MILLION)          280

TABLE 318         MIDDLE EAST: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION,  BY COUNTRY, 2022–2029 (USD MILLION)          280

TABLE 319         GCC COUNTRIES: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION,  BY COUNTRY, 2022–2029 (USD MILLION)          280

8.2.1      MONOCLONAL ANTIBODY PRODUCTION         281

8.2.1.1   Increasing regulatory approvals for mAb treatments to drive growth        281

TABLE 320         CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2022–2029 (USD MILLION)  281

TABLE 321         NORTH AMERICA: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          282

TABLE 322         EUROPE: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION,  BY COUNTRY, 2022–2029 (USD MILLION)   282

TABLE 323         ASIA PACIFIC: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION,  BY COUNTRY, 2022–2029 (USD MILLION)   282

TABLE 324         LATIN AMERICA: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          283

TABLE 325         MIDDLE EAST: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION,  BY COUNTRY, 2022–2029 (USD MILLION)   283

TABLE 326         GCC COUNTRIES: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          283

8.2.2      VACCINE PRODUCTION             284

8.2.2.1   Rising incidence of infectious diseases to drive growth 284

TABLE 327         CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY REGION,  2022–2029 (USD MILLION)     285

TABLE 328         NORTH AMERICA: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)             285

TABLE 329         EUROPE: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY,  2022–2029 (USD MILLION)          285

TABLE 330         ASIA PACIFIC: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)             286

TABLE 331         LATIN AMERICA: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)             286

TABLE 332         MIDDLE EAST: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)             286

TABLE 333         GCC COUNTRIES: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)             287

8.2.3      OTHER THERAPEUTIC PROTEIN PRODUCTION             287

TABLE 334         CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2022–2029 (USD MILLION)             287

TABLE 335         NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          288

TABLE 336         EUROPE: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION,  BY COUNTRY, 2022–2029 (USD MILLION)          288

TABLE 337         ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          288

TABLE 338         LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          289

TABLE 339         MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          289

TABLE 340         GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)          289

8.3         TISSUE ENGINEERING & REGENERATIVE MEDICINE      290

TABLE 341         CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)             290

TABLE 342         CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE,  BY REGION, 2022–2029 (USD MILLION)      291

TABLE 343         NORTH AMERICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)          291

TABLE 344         EUROPE: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)          291

TABLE 345         ASIA PACIFIC: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)          292

TABLE 346         LATIN AMERICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)          292

TABLE 347         MIDDLE EAST: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)          292

TABLE 348         GCC COUNTRIES: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)          293

8.3.1      CELL & GENE THERAPY 293

8.3.1.1   Increasing investments in cell-based therapies to drive market   293

TABLE 349         CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY REGION,  2022–2029 (USD MILLION)     294

TABLE 350         NORTH AMERICA: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)          294

TABLE 351         EUROPE: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY,  2022–2029 (USD MILLION)    294

TABLE 352         ASIA PACIFIC: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)       295

TABLE 353         LATIN AMERICA: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)       295

TABLE 354         MIDDLE EAST: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)       295

TABLE 355         GCC COUNTRIES: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)          296

8.3.2      OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS 296

TABLE 356         CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)              296

TABLE 357         NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     297

TABLE 358         EUROPE: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 297

TABLE 359         ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 297

TABLE 360         LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     298

TABLE 361         MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 298

TABLE 362         GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     298

8.4         DRUG SCREENING & DEVELOPMENT    299

8.4.1      INCREASING DEMAND FOR NOVEL THERAPEUTICS TO SUPPORT MARKET GROWTH        299

TABLE 363         CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION,  2022–2029 (USD MILLION)           299

TABLE 364         NORTH AMERICA: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)              300

TABLE 365         EUROPE: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT,  BY COUNTRY, 2022–2029 (USD MILLION)       300

TABLE 366         ASIA PACIFIC: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT,  BY COUNTRY, 2022–2029 (USD MILLION)              300

TABLE 367         LATIN AMERICA: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT,  BY COUNTRY, 2022–2029 (USD MILLION)              301

TABLE 368         MIDDLE EAST: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT,  BY COUNTRY, 2022–2029 (USD MILLION)              301

TABLE 369         GCC COUNTRIES: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT,  BY COUNTRY, 2022–2029 (USD MILLION)              301

8.5         OTHER APPLICATIONS 302

TABLE 370         CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)     302

TABLE 371         NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           302

TABLE 372         EUROPE: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        303

TABLE 373         ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           303

TABLE 374         LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           304

TABLE 375         MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           304

TABLE 376         GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           304

9            CELL EXPANSION MARKET, BY END USER          305

9.1         INTRODUCTION            306

TABLE 377         CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)          306

9.2         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES   306

9.2.1      GROWING STRATEGIC ALLIANCES BY KEY MARKET PLAYERS TO DRIVE GROWTH            306

TABLE 378         CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,  BY REGION, 2022–2029 (USD MILLION)              307

TABLE 379         NORTH AMERICA: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 307

TABLE 380         EUROPE: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)              308

TABLE 381         ASIA PACIFIC: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 308

TABLE 382         LATIN AMERICA: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 309

TABLE 383         MIDDLE EAST: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 309

TABLE 384         GCC COUNTRIES: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 309

9.3         RESEARCH & ACADEMIC INSTITUTES   310

9.3.1      INCREASING GOVERNMENT FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET       310

TABLE 385         CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION,  2022–2029 (USD MILLION)   310

TABLE 386         NORTH AMERICA: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)      311

TABLE 387         EUROPE: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES,  BY COUNTRY, 2022–2029 (USD MILLION)       311

TABLE 388         ASIA PACIFIC: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES,  BY COUNTRY, 2022–2029 (USD MILLION)       311

TABLE 389         LATIN AMERICA: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES,  BY COUNTRY, 2022–2029 (USD MILLION)       312

TABLE 390         MIDDLE EAST: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES,  BY COUNTRY, 2022–2029 (USD MILLION)       312

TABLE 391         GCC COUNTRIES: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)      312

9.4         HOSPITALS & DIAGNOSTIC LABORATORIES      313

9.4.1      GROWING DEMAND FOR CELL-BASED THERAPIES TO PROPEL MARKET            313

TABLE 392         CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION) 313

TABLE 393         NORTH AMERICA: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)              313

TABLE 394         EUROPE: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES,  BY COUNTRY, 2022–2029 (USD MILLION)              314

TABLE 395         ASIA PACIFIC: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)              314

TABLE 396         LATIN AMERICA: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)              315

TABLE 397         MIDDLE EAST: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)              315

TABLE 398         GCC COUNTRIES: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)              315

9.5         OTHER END USERS        316

TABLE 399         CELL EXPANSION MARKET FOR OTHER END USERS, BY REGION,  2022–2029 (USD MILLION)     316

TABLE 400         NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)    317

TABLE 401         EUROPE: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2029 (USD MILLION)         317

TABLE 402         ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2029 (USD MILLION)          317

TABLE 403         LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2029 (USD MILLION)          318

TABLE 404         MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2029 (USD MILLION)          318

TABLE 405         GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)             318

10          CELL EXPANSION MARKET, BY REGION 319

10.1       INTRODUCTION            320

TABLE 406         CELL EXPANSION MARKET, BY REGION, 2022–2029 (USD MILLION)          320

10.2       NORTH AMERICA          320

FIGURE 31         NORTH AMERICA: CELL EXPANSION MARKET SNAPSHOT              321

TABLE 407         NORTH AMERICA: CELL EXPANSION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          322

TABLE 408         NORTH AMERICA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          322

TABLE 409         NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)     322

TABLE 410         NORTH AMERICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          323

TABLE 411         NORTH AMERICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          323

TABLE 412         NORTH AMERICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 324

TABLE 413         NORTH AMERICA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)     324

TABLE 414         NORTH AMERICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 324

TABLE 415         NORTH AMERICA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)          325

TABLE 416         NORTH AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)     325

TABLE 417         NORTH AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)     325

TABLE 418         NORTH AMERICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)     326

TABLE 419         NORTH AMERICA: CELL EXPANSION MARKET, BY APPLICATION,  2022–2029 (USD MILLION)        326

TABLE 420         NORTH AMERICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              326

TABLE 421         NORTH AMERICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          327

TABLE 422         NORTH AMERICA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)          327

10.2.1    US         327

10.2.1.1 Rising investments in cell-based research to drive market          327

TABLE 423         US: CELL & GENE THERAPY APPROVALS, 2022   328

TABLE 424         US: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          328

TABLE 425         US: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          329

TABLE 426         US: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              329

TABLE 427         US: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              330

TABLE 428         US: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)              330

TABLE 429         US: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          330

TABLE 430         US: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          331

TABLE 431         US: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)          331

TABLE 432         US: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)          331

TABLE 433         US: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)          332

TABLE 434         US: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)          332

TABLE 435         US: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 332

TABLE 436         US: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE,  2022–2029 (USD MILLION)     333

TABLE 437         US: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)             333

TABLE 438         US: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)          333

10.2.2    CANADA            334

10.2.2.1 Growing funding for advancement of regenerative medicine to support market growth   334

TABLE 439         CANADA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 334

TABLE 440         CANADA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          335

TABLE 441         CANADA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              335

TABLE 442         CANADA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          336

TABLE 443         CANADA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          336

TABLE 444         CANADA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          336

TABLE 445         CANADA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          337

TABLE 446         CANADA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 337

TABLE 447         CANADA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)          337

TABLE 448         CANADA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)          338

TABLE 449         CANADA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)          338

TABLE 450         CANADA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     338

TABLE 451         CANADA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              339

TABLE 452         CANADA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          339

TABLE 453         CANADA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION) 339

10.2.3    NORTH AMERICA: RECESSION IMPACT 340

10.3       EUROPE             340

TABLE 454         EUROPE: NEW CELL THERAPY APPROVALS, 2022            340

TABLE 455         EUROPE: CELL EXPANSION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 341

TABLE 456         EUROPE: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 341

TABLE 457         EUROPE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          341

TABLE 458         EUROPE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              342

TABLE 459         EUROPE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          342

TABLE 460         EUROPE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          343

TABLE 461         EUROPE: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          343

TABLE 462         EUROPE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          343

TABLE 463         EUROPE: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 344

TABLE 464         EUROPE: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)          344

TABLE 465         EUROPE: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)          344

TABLE 466         EUROPE: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)          345

TABLE 467         EUROPE: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     345

TABLE 468         EUROPE: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              345

TABLE 469         EUROPE: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          346

TABLE 470         EUROPE: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION) 346

10.3.1    GERMANY         346

10.3.1.1 Increasing number of strategic alliances for development of cell-based therapies to drive market    346

TABLE 471         GERMANY: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     347

TABLE 472         GERMANY: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          347

TABLE 473         GERMANY: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          348

TABLE 474         GERMANY: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          348

TABLE 475         GERMANY: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          349

TABLE 476         GERMANY: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          349

TABLE 477         GERMANY: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          349

TABLE 478         GERMANY: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)     350

TABLE 479         GERMANY: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)          350

TABLE 480         GERMANY: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)          350

TABLE 481         GERMANY: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)          351

TABLE 482         GERMANY: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          351

TABLE 483         GERMANY: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              351

TABLE 484         GERMANY: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          352

TABLE 485         GERMANY: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)     352

10.3.2    UK         352

10.3.2.1 Increasing focus on advancement of regenerative medicine to propel market              352

TABLE 486         UK: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          353

TABLE 487         UK: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          353

TABLE 488         UK: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              353

TABLE 489         UK: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              354

TABLE 490         UK: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)              354

TABLE 491         UK: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          354

TABLE 492         UK: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          355

TABLE 493         UK: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)          355

TABLE 494         UK: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)          355

TABLE 495         UK: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)          356

TABLE 496         UK: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)          356

TABLE 497         UK: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 356

TABLE 498         UK: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE,  2022–2029 (USD MILLION)     357

TABLE 499         UK: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)             357

TABLE 500         UK: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)          357

10.3.3    FRANCE             358

10.3.3.1 Growing strategic alliances for development of advanced cell and gene therapies to support market growth   358

TABLE 501         FRANCE: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 358

TABLE 502         FRANCE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          358

TABLE 503         FRANCE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              359

TABLE 504         FRANCE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          359

TABLE 505         FRANCE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          360

TABLE 506         FRANCE: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          360

TABLE 507         FRANCE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          360

TABLE 508         FRANCE: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 361

TABLE 509         FRANCE: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)          361

TABLE 510         FRANCE: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)          361

TABLE 511         FRANCE: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)          362

TABLE 512         FRANCE: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     362

TABLE 513         FRANCE: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              362

TABLE 514         FRANCE: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          363

TABLE 515         FRANCE: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION) 363

10.3.4    ITALY   363

10.3.4.1 Increased focus on life sciences R&D activities and growing biotech industry to drive market        363

TABLE 516         ITALY: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 364

TABLE 517         ITALY: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          364

TABLE 518         ITALY: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              365

TABLE 519         ITALY: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              365

TABLE 520         ITALY: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          366

TABLE 521         ITALY: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          366

TABLE 522         ITALY: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          366

TABLE 523         ITALY: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 367

TABLE 524         ITALY: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)          367

TABLE 525         ITALY: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)          367

TABLE 526         ITALY: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)          368

TABLE 527         ITALY: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     368

TABLE 528         ITALY: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        368

TABLE 529         ITALY: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          369

TABLE 530         ITALY: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION) 369

10.3.5    SPAIN   369

10.3.5.1 Expansion of biotech companies to support market growth        369

TABLE 531         SPAIN: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 370

TABLE 532         SPAIN: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          370

TABLE 533         SPAIN: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              370

TABLE 534         SPAIN: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              371

TABLE 535         SPAIN: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          371

TABLE 536         SPAIN: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          371

TABLE 537         SPAIN: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          372

TABLE 538         SPAIN: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 372

TABLE 539         SPAIN: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)          372

TABLE 540         SPAIN: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)          373

TABLE 541         SPAIN: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)          373

TABLE 542         SPAIN: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     373

TABLE 543         SPAIN: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        374

TABLE 544         SPAIN: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          374

TABLE 545         SPAIN: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION) 374

10.3.6    REST OF EUROPE           375

TABLE 546         REST OF EUROPE: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          375

TABLE 547         REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)     375

TABLE 548         REST OF EUROPE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          376

TABLE 549         REST OF EUROPE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          376

TABLE 550         REST OF EUROPE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 377

TABLE 551         REST OF EUROPE: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)     377

TABLE 552         REST OF EUROPE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 377

TABLE 553         REST OF EUROPE: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)          378

TABLE 554         REST OF EUROPE: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)     378

TABLE 555        REST OF EUROPE: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)    378

TABLE 556         REST OF EUROPE: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)     379

TABLE 557         REST OF EUROPE: CELL EXPANSION MARKET, BY APPLICATION,  2022–2029 (USD MILLION)        379

TABLE 558         REST OF EUROPE: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              379

TABLE 559         REST OF EUROPE: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          380

TABLE 560         REST OF EUROPE: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)          380

10.3.7    EUROPE: RECESSION IMPACT   380

10.4       ASIA PACIFIC    381

FIGURE 32         ASIA PACIFIC: CELL EXPANSION MARKET SNAPSHOT   382

TABLE 561         ASIA PACIFIC: CELL EXPANSION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     383

TABLE 562         ASIA PACIFIC: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     383

TABLE 563         ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 383

TABLE 564         ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          384

TABLE 565         ASIA PACIFIC: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          384

TABLE 566         ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          385

TABLE 567         ASIA PACIFIC: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION) 385

TABLE 568         ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 385

TABLE 569         ASIA PACIFIC: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)     386

TABLE 570         ASIA PACIFIC: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)    386

TABLE 571         ASIA PACIFIC: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)          386

TABLE 572         ASIA PACIFIC: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)    387

TABLE 573         ASIA PACIFIC: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          387

TABLE 574         ASIA PACIFIC: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION,  BY TYPE, 2022–2029 (USD MILLION)              387

TABLE 575         ASIA PACIFIC: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          388

TABLE 576         ASIA PACIFIC: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)     388

10.4.1    CHINA  388

10.4.1.1 Increasing R&D expenditure and rising number of clinical trials for novel therapeutics to propel market          388

TABLE 577         CHINA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 389

TABLE 578         CHINA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          389

TABLE 579         CHINA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              390

TABLE 580         CHINA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              390

TABLE 581         CHINA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          390

TABLE 582         CHINA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          391

TABLE 583         CHINA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          391

TABLE 584         CHINA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 391

TABLE 585         CHINA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)          392

TABLE 586         CHINA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)          392

TABLE 587         CHINA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)          392

TABLE 588         CHINA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     393

TABLE 589         CHINA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              393

TABLE 590         CHINA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          393

TABLE 591         CHINA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION) 394

10.4.2    JAPAN  394

10.4.2.1 Rising investments for advancement of biotechnology sector to boost market growth   394

TABLE 592         JAPAN: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 395

TABLE 593         JAPAN: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          395

TABLE 594         JAPAN: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              395

TABLE 595         JAPAN: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              396

TABLE 596         JAPAN: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          396

TABLE 597         JAPAN: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          396

TABLE 598         JAPAN: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          397

TABLE 599         JAPAN: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 397

TABLE 600         JAPAN: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)          397

TABLE 601         JAPAN: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)          398

TABLE 602         JAPAN: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)          398

TABLE 603         JAPAN: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     398

TABLE 604         JAPAN: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        399

TABLE 605         JAPAN: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          399

TABLE 606         JAPAN: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION) 399

10.4.3    INDIA   400

10.4.3.1 Rising funding to boost biopharmaceutical sector and growing focus on development of cell-based therapies to propel market  400

TABLE 607         INDIA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 400

TABLE 608         INDIA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          401

TABLE 609         INDIA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              401

TABLE 610         INDIA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              402

TABLE 611         INDIA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          402

TABLE 612         INDIA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          402

TABLE 613         INDIA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          403

TABLE 614         INDIA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 403

TABLE 615         INDIA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)          403

TABLE 616         INDIA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)          404

TABLE 617         INDIA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)          404

TABLE 618         INDIA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     404

TABLE 619         INDIA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)        405

TABLE 620         INDIA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          405

TABLE 621         INDIA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION) 405

10.4.4    SOUTH KOREA 406

10.4.4.1 Growing strategic alliances and investments in research to drive market  406

TABLE 622         SOUTH KOREA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          406

TABLE 623         SOUTH KOREA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 407

TABLE 624         SOUTH KOREA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          407

TABLE 625         SOUTH KOREA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          408

TABLE 626         SOUTH KOREA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 408

TABLE 627         SOUTH KOREA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION) 408

TABLE 628         SOUTH KOREA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 409

TABLE 629         SOUTH KOREA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)          409

TABLE 630        SOUTH KOREA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)    409

TABLE 631         SOUTH KOREA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)    410

TABLE 632         SOUTH KOREA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)     410

TABLE 633         SOUTH KOREA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          410

TABLE 634         SOUTH KOREA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION,  BY TYPE, 2022–2029 (USD MILLION)              411

TABLE 635         SOUTH KOREA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          411

TABLE 636         SOUTH KOREA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)          411

10.4.5    AUSTRALIA       412

10.4.5.1 Growing life science sector to drive market    412

TABLE 637         AUSTRALIA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     412

TABLE 638         AUSTRALIA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 412

TABLE 639         AUSTRALIA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          413

TABLE 640         AUSTRALIA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          413

TABLE 641         AUSTRALIA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          413

TABLE 642         AUSTRALIA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION) 414

TABLE 643         AUSTRALIA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          414

TABLE 644         AUSTRALIA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)     414

TABLE 645         AUSTRALIA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)    415

TABLE 646         AUSTRALIA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)          415

TABLE 647         AUSTRALIA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)    415

TABLE 648         AUSTRALIA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          416

TABLE 649         AUSTRALIA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION,  BY TYPE, 2022–2029 (USD MILLION)              416

TABLE 650         AUSTRALIA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          416

TABLE 651         AUSTRALIA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)     417

10.4.6    REST OF ASIA PACIFIC  417

TABLE 652         REST OF ASIA PACIFIC: CELL EXPANSION MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 418

TABLE 653         REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          418

TABLE 654         REST OF ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION) 418

TABLE 655         REST OF ASIA PACIFIC: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION) 419

TABLE 656         REST OF ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     419

TABLE 657         REST OF ASIA PACIFIC: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          419

TABLE 658         REST OF ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)     420

TABLE 659         REST OF ASIA PACIFIC: CELL EXPANSION MARKET, BY CELL TYPE,  2022–2029 (USD MILLION)          420

TABLE 660         REST OF ASIA PACIFIC: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)    420

TABLE 661         REST OF ASIA PACIFIC: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)     421

TABLE 662         REST OF ASIA PACIFIC: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)    421

TABLE 663         REST OF ASIA PACIFIC: CELL EXPANSION MARKET, BY APPLICATION,  2022–2029 (USD MILLION)        421

TABLE 664         REST OF ASIA PACIFIC: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              422

TABLE 665         REST OF ASIA PACIFIC: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          422

TABLE 666         REST OF ASIA PACIFIC: CELL EXPANSION MARKET, BY END USER,  2022–2029 (USD MILLION)          422

10.4.7    ASIA PACIFIC: RECESSION IMPACT        423

10.5       LATIN AMERICA             423

TABLE 667         LATIN AMERICA: CELL EXPANSION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          423

TABLE 668         LATIN AMERICA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          424

TABLE 669         LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 424

TABLE 670         LATIN AMERICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          424

TABLE 671         LATIN AMERICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          425

TABLE 672         LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 425

TABLE 673         LATIN AMERICA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)     425

TABLE 674         LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 426

TABLE 675         LATIN AMERICA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)          426

TABLE 676         LATIN AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)     426

TABLE 677         LATIN AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)    427

TABLE 678         LATIN AMERICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)     427

TABLE 679        LATIN AMERICA: CELL EXPANSION MARKET, BY APPLICATION,  2022–2029 (USD MILLION)          427

TABLE 680         LATIN AMERICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION,  BY TYPE, 2022–2029 (USD MILLION)              428

TABLE 681         LATIN AMERICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          428

TABLE 682         LATIN AMERICA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)          428

10.5.1    BRAZIL 429

10.5.1.1 Increasing demand for biopharmaceuticals to drive market        429

TABLE 683         BRAZIL: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 429

TABLE 684         BRAZIL: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          429

TABLE 685         BRAZIL: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              430

TABLE 686         BRAZIL: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              430

TABLE 687         BRAZIL: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          430

TABLE 688         BRAZIL: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          431

TABLE 689         BRAZIL: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          431

TABLE 690         BRAZIL: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 431

TABLE 691         BRAZIL: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)          432

TABLE 692         BRAZIL: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)          432

TABLE 693         BRAZIL: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)          432

TABLE 694         BRAZIL: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     433

TABLE 695         BRAZIL: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              433

TABLE 696         BRAZIL: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          433

TABLE 697         BRAZIL: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION) 434

10.5.2    MEXICO             434

10.5.2.1 Increasing government support for biopharmaceutical production to support market growth     434

TABLE 698         MEXICO: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 434

TABLE 699         MEXICO: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          435

TABLE 700         MEXICO: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              435

TABLE 701         MEXICO: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          436

TABLE 702         MEXICO: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          436

TABLE 703         MEXICO: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          436

TABLE 704         MEXICO: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          437

TABLE 705         MEXICO: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 437

TABLE 706         MEXICO: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)          437

TABLE 707         MEXICO: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)          438

TABLE 708         MEXICO: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)          438

TABLE 709         MEXICO: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     438

TABLE 710         MEXICO: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              439

TABLE 711         MEXICO: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          439

TABLE 712         MEXICO: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION) 439

10.5.3    REST OF LATIN AMERICA          440

TABLE 713         REST OF LATIN AMERICA: CELL EXPANSION MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 440

TABLE 714         REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)          440

TABLE 715         REST OF LATIN AMERICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION) 441

TABLE 716         REST OF LATIN AMERICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)     441

TABLE 717         REST OF LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          442

TABLE 718         REST OF LATIN AMERICA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          442

TABLE 719         REST OF LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          442

TABLE 720         REST OF LATIN AMERICA: CELL EXPANSION MARKET, BY CELL TYPE,  2022–2029 (USD MILLION)          443

TABLE 721         REST OF LATIN AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)       443

TABLE 722         REST OF LATIN AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)        443

TABLE 723         REST OF LATIN AMERICA: CELL EXPANSION MARKET FOR ANIMAL CELLS,  BY TYPE, 2022–2029 (USD MILLION)    444

TABLE 724         REST OF LATIN AMERICA: CELL EXPANSION MARKET, BY APPLICATION,  2022–2029 (USD MILLION)        444

TABLE 725         REST OF LATIN AMERICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              444

TABLE 726         REST OF LATIN AMERICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          445

TABLE 727         REST OF LATIN AMERICA: CELL EXPANSION MARKET, BY END USER,  2022–2029 (USD MILLION)          445

10.5.4    LATIN AMERICA: RECESSION IMPACT   445

10.6       MIDDLE EAST  446

TABLE 728         MIDDLE EAST: CELL EXPANSION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     446

TABLE 729         MIDDLE EAST: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     446

TABLE 730         MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 447

TABLE 731         MIDDLE EAST: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          447

TABLE 732         MIDDLE EAST: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          448

TABLE 733         MIDDLE EAST: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          448

TABLE 734         MIDDLE EAST: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION) 448

TABLE 735         MIDDLE EAST: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 449

TABLE 736         MIDDLE EAST: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)          449

TABLE 737         MIDDLE EAST: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)    449

TABLE 738         MIDDLE EAST: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)    450

TABLE 739         MIDDLE EAST: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)    450

TABLE 740         MIDDLE EAST: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          450

TABLE 741         MIDDLE EAST: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION,  BY TYPE, 2022–2029 (USD MILLION)              451

TABLE 742         MIDDLE EAST: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          451

TABLE 743         MIDDLE EAST: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)     451

10.6.1    GCC COUNTRIES           452

TABLE 744         GCC COUNTRIES: CELL EXPANSION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          452

TABLE 745         GCC COUNTRIES: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          452

TABLE 746         GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)     453

TABLE 747         GCC COUNTRIES: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          453

TABLE 748         GCC COUNTRIES: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          454

TABLE 749         GCC COUNTRIES: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 454

TABLE 750         GCC COUNTRIES: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)     454

TABLE 751         GCC COUNTRIES: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 455

TABLE 752         GCC COUNTRIES: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)          455

TABLE 753         GCC COUNTRIES: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)     455

TABLE 754        GCC COUNTRIES: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)    456

TABLE 755         GCC COUNTRIES: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)     456

TABLE 756         GCC COUNTRIES: CELL EXPANSION MARKET, BY APPLICATION,  2022–2029 (USD MILLION)        456

TABLE 757         GCC COUNTRIES: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION,  BY TYPE, 2022–2029 (USD MILLION)              457

TABLE 758         GCC COUNTRIES: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          457

TABLE 759         GCC COUNTRIES: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)          457

10.6.1.1 Saudi Arabia        458

10.6.1.1.1            Increasing focus of key players on expansion strategies to drive market              458

TABLE 760         SAUDI ARABIA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          458

TABLE 761         SAUDI ARABIA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 458

TABLE 762         SAUDI ARABIA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)          459

TABLE 763         SAUDI ARABIA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)          459

TABLE 764         SAUDI ARABIA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 460

TABLE 765         SAUDI ARABIA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION) 460

TABLE 766         SAUDI ARABIA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 460

TABLE 767         SAUDI ARABIA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)          461

TABLE 768        SAUDI ARABIA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)    461

TABLE 769         SAUDI ARABIA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)    461

TABLE 770        SAUDI ARABIA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)    462

TABLE 771         SAUDI ARABIA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          462

TABLE 772         SAUDI ARABIA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION,  BY TYPE, 2022–2029 (USD MILLION)              462

TABLE 773         SAUDI ARABIA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          463

TABLE 774         SAUDI ARABIA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)          463

10.6.1.2 United Arab Emirates        463

10.6.1.2.1            Governmental initiatives to support market growth      463

TABLE 775         UNITED ARAB EMIRATES: CELL EXPANSION MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 464

TABLE 776         UNITED ARAB EMIRATES: CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)          464

TABLE 777         UNITED ARAB EMIRATES: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION) 465

TABLE 778         UNITED ARAB EMIRATES: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)     465

TABLE 779         UNITED ARAB EMIRATES: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          466

TABLE 780         UNITED ARAB EMIRATES: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          466

TABLE 781         UNITED ARAB EMIRATES: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          466

TABLE 782         UNITED ARAB EMIRATES: CELL EXPANSION MARKET, BY CELL TYPE,  2022–2029 (USD MILLION)          467

TABLE 783         UNITED ARAB EMIRATES: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)    467

TABLE 784         UNITED ARAB EMIRATES: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)        467

TABLE 785         UNITED ARAB EMIRATES: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)    468

TABLE 786         UNITED ARAB EMIRATES: CELL EXPANSION MARKET, BY APPLICATION,  2022–2029 (USD MILLION)        468

TABLE 787         UNITED ARAB EMIRATES: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              468

TABLE 788         UNITED ARAB EMIRATES: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          469

TABLE 789         UNITED ARAB EMIRATES: CELL EXPANSION MARKET, BY END USER,  2022–2029 (USD MILLION)          469

10.6.1.3 Rest of GCC countries       469

TABLE 790         REST OF GCC COUNTRIES: CELL EXPANSION MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 470

TABLE 791         REST OF GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)          470

TABLE 792         REST OF GCC COUNTRIES: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)     471

TABLE 793         REST OF GCC COUNTRIES: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)     471

TABLE 794         REST OF GCC COUNTRIES: EQUIPMENT MARKET, BY TYPE,  2022–2029 (USD MILLION)          472

TABLE 795         REST OF GCC COUNTRIES: BIOREACTORS MARKET, BY USAGE,  2022–2029 (USD MILLION)          472

TABLE 796         REST OF GCC COUNTRIES: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          472

TABLE 797         REST OF GCC COUNTRIES: CELL EXPANSION MARKET, BY CELL TYPE,  2022–2029 (USD MILLION) 473

TABLE 798         REST OF GCC COUNTRIES: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)       473

TABLE 799         REST OF GCC COUNTRIES: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)        473

TABLE 800         REST OF GCC COUNTRIES: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)      474

TABLE 801         REST OF GCC COUNTRIES: CELL EXPANSION MARKET, BY APPLICATION,  2022–2029 (USD MILLION)        474

TABLE 802         REST OF GCC COUNTRIES: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              474

TABLE 803         REST OF GCC COUNTRIES: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          475

TABLE 804         REST OF GCC COUNTRIES: CELL EXPANSION MARKET, BY END USER,  2022–2029 (USD MILLION)          475

10.6.2    REST OF THE MIDDLE EAST      475

TABLE 805         REST OF MIDDLE EAST: CELL EXPANSION MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 476

TABLE 806         REST OF MIDDLE EAST: CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)          476

TABLE 807         REST OF MIDDLE EAST: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION) 477

TABLE 808         REST OF MIDDLE EAST: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION) 477

TABLE 809         REST OF MIDDLE EAST: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     478

TABLE 810         REST OF MIDDLE EAST: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          478

TABLE 811         REST OF MIDDLE EAST: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          478

TABLE 812         REST OF MIDDLE EAST: CELL EXPANSION MARKET, BY CELL TYPE,  2022–2029 (USD MILLION)          479

TABLE 813         REST OF MIDDLE EAST: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)    479

TABLE 814         REST OF MIDDLE EAST: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)     479

TABLE 815         REST OF MIDDLE EAST: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)    480

TABLE 816         REST OF MIDDLE EAST: CELL EXPANSION MARKET, BY APPLICATION,  2022–2029 (USD MILLION)        480

TABLE 817         REST OF MIDDLE EAST: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              480

TABLE 818         REST OF MIDDLE EAST: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          481

TABLE 819         REST OF MIDDLE EAST: CELL EXPANSION MARKET, BY END USER,  2022–2029 (USD MILLION)          481

10.6.3    MIDDLE EAST: RECESSION IMPACT       481

10.7       AFRICA 482

10.7.1    RISING FUNDING ACTIVITIES FOR BIOPHARMA AND CELL & GENE THERAPY TO FUEL MARKET GROWTH 482

10.7.2    AFRICA: RECESSION IMPACT     482

TABLE 820         AFRICA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 483

TABLE 821         AFRICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          483

TABLE 822         AFRICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)              483

TABLE 823         AFRICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)              484

TABLE 824         AFRICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          484

TABLE 825         AFRICA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)          484

TABLE 826         AFRICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)          485

TABLE 827         AFRICA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 485

TABLE 828         AFRICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE,  2022–2029 (USD MILLION)          485

TABLE 829         AFRICA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE,  2022–2029 (USD MILLION)          486

TABLE 830         AFRICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE,  2022–2029 (USD MILLION)          486

TABLE 831         AFRICA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     486

TABLE 832         AFRICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)              487

TABLE 833         AFRICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)          487

TABLE 834         AFRICA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION) 487

11          COMPETITIVE LANDSCAPE       488

11.1       OVERVIEW        488

11.2       STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN           488

TABLE 835         STRATEGIES ADOPTED BY KEY PLAYERS IN CELL EXPANSION MARKET, 2021–2024       488

11.3       REVENUE SHARE ANALYSIS       490

FIGURE 33         REVENUE SHARE ANALYSIS OF KEY PLAYERS IN CELL EXPANSION MARKET, 2019–2023 (USD MILLION)            490

11.4       MARKET SHARE ANALYSIS         490

FIGURE 34         CELL EXPANSION MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)   491

TABLE 836         CELL EXPANSION MARKET: DEGREE OF COMPETITION              491

11.5       BRAND/PRODUCT COMPARATIVE ANALYSIS    493

FIGURE 35         BRAND/PRODUCT COMPARATIVE ANALYSIS    493

11.6       COMPANY EVALUATION MATRIX: KEY PLAYERS            493

11.6.1    STARS  494

11.6.2    EMERGING LEADERS    494

11.6.3    PERVASIVE PLAYERS     494

11.6.4    PARTICIPANTS 494

FIGURE 36         CELL EXPANSION MARKET: COMPANY EVALUATION MATRIX  (KEY PLAYERS), 2023     495

11.7       COMPANY FOOTPRINT: KEY PLAYERS  496

11.7.1    COMPANY FOOTPRINT 496

FIGURE 37         CELL EXPANSION MARKET: COMPANY FOOTPRINT      496

11.7.2    REGIONAL FOOTPRINT             497

TABLE 837         CELL EXPANSION MARKET: REGIONAL FOOTPRINT      497

11.7.3    PRODUCT FOOTPRINT 498

TABLE 838         CELL EXPANSION MARKET: PRODUCT FOOTPRINT      498

11.7.4    APPLICATION FOOTPRINT       499

TABLE 839         CELL EXPANSION MARKET: APPLICATION FOOTPRINT 499

11.7.5    END-USER FOOTPRINT 500

TABLE 840         CELL EXPANSION MARKET: END-USER FOOTPRINT      500

11.8       COMPANY EVALUATION MATRIX: STARTUPS/SMES      501

11.8.1    PROGRESSIVE COMPANIES       501

11.8.2    STARTING BLOCKS       501

11.8.3    RESPONSIVE COMPANIES          501

11.8.4    DYNAMIC COMPANIES 501

FIGURE 38         CELL EXPANSION MARKET: COMPANY EVALUATION MATRIX  (STARTUPS/SMES), 2023             502

11.8.5    COMPETITIVE BENCHMARKING: STARTUPS/SMES        503

TABLE 841         CELL EXPANSION MARKET: DETAILED LIST OF KEY STARTUPS/SMES           503

TABLE 842         CELL EXPANSION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/ SMES, 2023 504

11.9       VALUATION AND FINANCIAL METRICS OF CELL EXPANSION VENDORS          505

FIGURE 39         EV/EBITDA OF KEY VENDORS   505

FIGURE 40         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF  KEY VENDORS           505

11.10     COMPETITIVE SCENARIO          506

11.10.1  PRODUCT LAUNCHES  506

TABLE 843         CELL EXPANSION MARKET: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2024       506

11.10.2  DEALS  507

TABLE 844         CELL EXPANSION MARKET: DEALS, JANUARY 2021–JANUARY 2024      507

11.10.3  EXPANSIONS    508

TABLE 845         CELL EXPANSION MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2024  508

12          COMPANY PROFILES    509

(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *

12.1       INTRODUCTION            509

12.2       KEY PLAYERS   509

12.2.1    THERMO FISHER SCIENTIFIC INC.          509

TABLE 846         THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW              509

FIGURE 41         THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)   510

TABLE 847         THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED              510

TABLE 848         THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES              515

TABLE 849         THERMO FISHER SCIENTIFIC INC.: DEALS          516

TABLE 850         THERMO FISHER SCIENTIFIC INC.: EXPANSIONS            516

12.2.2    DANAHER CORPORATION         519

TABLE 851         DANAHER CORPORATION: COMPANY OVERVIEW         519

FIGURE 42         DANAHER CORPORATION: COMPANY SNAPSHOT (2023)              520

TABLE 852         DANAHER CORPORATION: PRODUCTS OFFERED          520

TABLE 853         DANAHER CORPORATION: PRODUCT LAUNCHES         525

TABLE 854         DANAHER CORPORATION: DEALS         525

TABLE 855         DANAHER CORPORATION: EXPANSIONS           527

TABLE 856         DANAHER CORPORATION: OTHER DEVELOPMENTS    528

12.2.3    MERCK KGAA   529

TABLE 857         MERCK KGAA: COMPANY OVERVIEW    529

FIGURE 43         MERCK KGAA: COMPANY SNAPSHOT (2023)      530

TABLE 858         MERCK KGAA: PRODUCTS OFFERED     530

TABLE 859         MERCK KGAA: DEALS   534

TABLE 860         MERCK KGAA: EXPANSIONS      535

12.2.4    SARTORIUS AG 537

TABLE 861         SARTORIUS AG: COMPANY OVERVIEW 537

FIGURE 44         SARTORIUS AG: COMPANY SNAPSHOT (2023)   538

TABLE 862         SARTORIUS AG: PRODUCTS OFFERED  538

TABLE 863         SARTORIUS AG: DEALS 542

TABLE 864         SARTORIUS AG: EXPANSIONS   543

12.2.5    CORNING INCORPORATED       545

TABLE 865         CORNING INCORPORATED: COMPANY OVERVIEW        545

FIGURE 45         CORNING INCORPORATED: COMPANY SNAPSHOT (2023)              546

TABLE 866         CORNING INCORPORATED: PRODUCTS OFFERED         546

TABLE 867         CORNING INCORPORATED: PRODUCT LAUNCHES        551

TABLE 868         CORNING INCORPORATED: DEALS       551

12.2.6    LONZA 552

TABLE 869         LONZA: COMPANY OVERVIEW 552

FIGURE 46         LONZA: COMPANY SNAPSHOT (2023)    553

TABLE 870         LONZA: PRODUCTS OFFERED  553

TABLE 871         LONZA: PRODUCT LAUNCHES 557

TABLE 872         LONZA: DEALS 557

TABLE 873         LONZA: EXPANSIONS    558

12.2.7    TERUMO CORPORATION           559

TABLE 874         TERUMO CORPORATION: COMPANY OVERVIEW           559

FIGURE 47         TERUMO CORPORATION: COMPANY SNAPSHOT (2022)              560

TABLE 875         TERUMO CORPORATION: PRODUCTS OFFERED            560

TABLE 876         TERUMO CORPORATION: PRODUCT LAUNCHES           561

TABLE 877         TERUMO CORPORATION: DEALS           561

12.2.8    EPPENDORF SE 562

TABLE 878         EPPENDORF SE: COMPANY OVERVIEW 562

FIGURE 48         EPPENDORF SE: COMPANY SNAPSHOT (2022)   563

TABLE 879         EPPENDORF SE: PRODUCTS OFFERED  563

TABLE 880         EPPENDORF SE: PRODUCT LAUNCHES 564

TABLE 881         EPPENDORF SE: EXPANSIONS   565

12.2.9    FUJIFILM CORPORATION           566

TABLE 882         FUJIFILM CORPORATION: COMPANY OVERVIEW           566

FIGURE 49         FUJIFILM CORPORATION: COMPANY SNAPSHOT (2022)              567

TABLE 883         FUJIFILM CORPORATION: PRODUCTS OFFERED            567

TABLE 884         FUJIFILM CORPORATION: PRODUCT LAUNCHES           572

TABLE 885         FUJIFILM CORPORATION: DEALS           573

TABLE 886         FUJIFILM CORPORATION: EXPANSIONS             573

12.2.10  BIO-TECHNE    575

TABLE 887         BIO-TECHNE: COMPANY OVERVIEW     575

FIGURE 50         BIO-TECHNE: COMPANY SNAPSHOT (2023)       576

TABLE 888         BIO-TECHNE: PRODUCTS OFFERED      576

TABLE 889         BIO-TECHNE: PRODUCT LAUNCHES     580

TABLE 890         BIO-TECHNE: DEALS    580

12.2.11  REPLIGEN CORPORATION        581

TABLE 891         REPLIGEN CORPORATION: COMPANY OVERVIEW         581

FIGURE 51         REPLIGEN CORPORATION: COMPANY SNAPSHOT (2023)              582

TABLE 892         REPLIGEN CORPORATION: PRODUCTS OFFERED          582

TABLE 893         REPLIGEN CORPORATION: DEALS         583

12.2.12  GETINGE AB     584

TABLE 894         GETINGE AB: COMPANY OVERVIEW      584

FIGURE 52         GETINGE AB: COMPANY SNAPSHOT (2022)        585

TABLE 895         GETINGE AB: PRODUCTS OFFERED      585

TABLE 896         GETINGE AB: PRODUCT LAUNCHES     586

TABLE 897         GETINGE AB: DEALS     586

12.2.13  BD         587

TABLE 898         BD: BUSINESS OVERVIEW          587

FIGURE 53         BD: COMPANY SNAPSHOT (2023)           588

TABLE 899         BD: PRODUCTS OFFERED          588

12.2.14  MILTENYI BIOTEC         590

TABLE 900         MILTENYI BIOTEC: COMPANY OVERVIEW         590

TABLE 901         MILTENYI BIOTEC: PRODUCTS OFFERED          590

TABLE 902         MILTENYI BIOTEC: EXPANSIONS            593

12.2.15  PERKINELMER INC.       594

TABLE 903         PERKINELMER INC.: COMPANY OVERVIEW        594

FIGURE 54         PERKINELMER INC.: COMPANY SNAPSHOT (2022)          595

TABLE 904         PERKINELMER INC.: PRODUCTS OFFERED         595

TABLE 905         PERKINELMER INC.: DEALS       597

12.2.16  STEMCELL TECHNOLOGIES      598

TABLE 906         STEMCELL TECHNOLOGIES: COMPANY OVERVIEW      598

TABLE 907         STEMCELL TECHNOLOGIES: PRODUCTS OFFERED       598

TABLE 908         STEMCELL TECHNOLOGIES: DEALS      601

12.2.17  PROMOCELL GMBH      602

TABLE 909         PROMOCELL GMBH: COMPANY OVERVIEW       602

TABLE 910         PROMOCELL GMBH: PRODUCTS OFFERED       602

TABLE 911         PROMOCELL GMBH: PRODUCT LAUNCHES      603

12.2.18  HIMEDIA LABORATORIES          604

TABLE 912         HIMEDIA LABORATORIES: COMPANY OVERVIEW           604

TABLE 913         HIMEDIA LABORATORIES: PRODUCTS OFFERED           604

12.3       OTHER PLAYERS           607

12.3.1    TAKARA BIO INC.           607

TABLE 914         TAKARA BIO INC.: BUSINESS OVERVIEW             607

12.3.2    SHANGHAI DUONING BIOTECHNOLOGY CO., LTD.       608

TABLE 915         SHANGHAI DUONING BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW        608

12.3.3    REPROCELL INC.            609

TABLE 916         REPROCELL INC.: BUSINESS OVERVIEW 609

TABLE 917         PBS BIOTECH, INC.: BUSINESS OVERVIEW          610

12.3.4    ACROBIOSYSTEMS        611

TABLE 918         ACROBIOSYSTEMS: COMPANY OVERVIEW         611

12.3.5    SOLIDA BIOTECH GMBH            614

TABLE 919         SOLIDA BIOTECH GMBH: BUSINESS OVERVIEW 614

12.3.6    BEIJING CYTONICHE BIOTECHNOLOGY CO., LTD.         615

TABLE 920         BEIJING CYTONICHE BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW        615

12.3.7    NEUROMICS     616

TABLE 921         NEUROMICS: BUSINESS OVERVIEW       616

12.3.8    BIONET              617

TABLE 922         BIONET: BUSINESS OVERVIEW 617

12.3.9    CELLEXUS         618

TABLE 923         CELLEXUS: BUSINESS OVERVIEW           618

*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

13          APPENDIX         619

13.1       DISCUSSION GUIDE      619

13.2       KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL             626

13.3       CUSTOMIZATION OPTIONS      628

13.4       RELATED REPORTS       628

13.5       AUTHOR DETAILS         629